Valuation: Kamada Ltd.

Market Cap 1.3B 0 434M 380M 350M 325M 618M 41.43B 626M 4.19B 1.63B 20.34B 1.63B 1.6B 70.51B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.3B 0 434M 380M 350M 325M 618M 41.43B 626M 4.19B 1.63B 20.34B 1.63B 1.6B 70.51B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 2.03x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 30/06/2015
Director of Finance/CFO 55 30/12/2017
Chief Operating Officer 53 31/10/2016
Director TitleAgeSince
Director/Board Member 75 12/12/1990
Chairman 77 06/03/2013
Chairman 55 11/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.04% - - 434M
+3.05%+7.24%+24.27%-3.43% 66.11B
-0.24%-3.13%+49.38%+223.97% 55.3B
+1.21%+42.20%+42.20%+42.20% 42.44B
-0.21%+7.44%-48.93%-54.50% 41.28B
-2.55%+13.21%+165.15%-33.31% 32.46B
+0.78%-2.67%+61.60%-23.55% 30.78B
+1.79%+3.64%+74.65%+89.29% 23.1B
-3.65%+8.93%+1.16%+184.50% 20.06B
-0.04%+3.68%+67.48%+135.50% 17.19B
Average -0.01%+5.33%+48.55%+62.30% 36.52B
Weighted average by Cap. +0.45%+4.16%+43.41%+54.72%

Financials

2026 *2027 *
Net sales 585M 0 195M 171M 157M 146M 277M 18.61B 281M 1.88B 733M 9.14B 733M 717M 31.68B 642M 0 214M 188M 173M 160M 305M 20.43B 309M 2.07B 805M 10.03B 804M 787M 34.78B
Net income 72.01M 0 24.03M 21.05M 19.39M 17.99M 34.17M 2.29B 34.63M 232M 90.31M 1.13B 90.25M 88.27M 3.9B 104M 0 34.59M 30.29M 27.9M 25.9M 49.18M 3.3B 49.85M 334M 130M 1.62B 130M 127M 5.62B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-